Brief: Helix Biopharma says Heman Chao to become CEO
07/03/2017 12:45
March 7 (Reuters) - Helix Biopharma Corp HBP.TO
* Announces strategic management changes
* Dr. Sven Rohmann, CEO and chairman of company, will be
stepping down from his position as chief executive officer
* Heman Chao will assume position of chief executive officer
Source text for Eikon: ID:nMKWzb02ba
Further company coverage: HBP.TO
(Bangalore.newsroom@thomsonreuters.com)
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020